MEDINET (2370) Stock Overview
Operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
2370 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MEDINET Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥32.00 |
| 52 Week High | JP¥43.00 |
| 52 Week Low | JP¥27.00 |
| Beta | 0 |
| 1 Month Change | 3.23% |
| 3 Month Change | -8.57% |
| 1 Year Change | -13.51% |
| 3 Year Change | -54.29% |
| 5 Year Change | -44.83% |
| Change since IPO | -95.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2370 | JP Life Sciences | JP Market | |
|---|---|---|---|
| 7D | 10.3% | -2.1% | 1.3% |
| 1Y | -13.5% | -5.6% | 25.5% |
Return vs Industry: 2370 underperformed the JP Life Sciences industry which returned -5.6% over the past year.
Return vs Market: 2370 underperformed the JP Market which returned 25.5% over the past year.
Price Volatility
| 2370 volatility | |
|---|---|
| 2370 Average Weekly Movement | 7.3% |
| Life Sciences Industry Average Movement | 6.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 8.0% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 2370's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 2370's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | n/a | Kanenao Kubushiro | www.medinet-inc.co.jp |
MEDINET Co., Ltd. operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan. It operates through two segments: Cell Processing Business and Regenerative Medicine Products Business The company’s solutions include technical know-how, facilities, systems, materials, professional cell-engineers, and other requirements to conduct immuno-cell therapy
MEDINET Co., Ltd. Fundamentals Summary
| 2370 fundamental statistics | |
|---|---|
| Market cap | JP¥7.68b |
| Earnings (TTM) | -JP¥3.05b |
| Revenue (TTM) | JP¥998.00m |
Is 2370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2370 income statement (TTM) | |
|---|---|
| Revenue | JP¥998.00m |
| Cost of Revenue | JP¥668.00m |
| Gross Profit | JP¥330.00m |
| Other Expenses | JP¥3.38b |
| Earnings | -JP¥3.05b |
Last Reported Earnings
Sep 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did 2370 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/06 10:51 |
| End of Day Share Price | 2026/01/06 00:00 |
| Earnings | 2018/09/30 |
| Annual Earnings | 2018/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MEDINET Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kiyokazu Yamazaki | Ichiyoshi Research Institute Inc. |